Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-031539

Chief Financial Officer sold 50,000 shares at $40.00 ($2,000,000)

  • Chief Financial Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Cohen Chad M · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-19 Exercise or conversion : show line 1 in the form +30,000 $4.07 $122,100 31,000 D
2020-05-19 Exercise or conversion : show line 2 in the form +20,000 $6.32 $126,400 51,000 D
2020-05-19 Sale : show line 3 in the form −50,000 $40.00 $2,000,000 1,000 D
Open-market sales · 50,000 sh · avg $40.00 · $2,000,000

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-05-19 Exercise or conversion : show line 4 in the form Stock Option (Right To Buy) −20,000 700,000 D
2020-05-19 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −30,000 0 D
Loading xslF345X03/doc4.xml…